These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12642787)

  • 1. Hepatic lipase: a marker for cardiovascular disease risk and response to therapy.
    Zambon A; Deeb SS; Pauletto P; Crepaldi G; Brunzell JD
    Curr Opin Lipidol; 2003 Apr; 14(2):179-89. PubMed ID: 12642787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol.
    Zambon A; Deeb SS; Hokanson JE; Brown BG; Brunzell JD
    Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1723-9. PubMed ID: 9812910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the --514 C-->T polymorphism of the hepatic lipase gene promoter and unstable carotid plaque in patients with severe carotid artery stenosis.
    Faggin E; Zambon A; Puato M; Deeb SS; Bertocco S; Sartore S; Crepaldi G; Pessina AC; Pauletto P
    J Am Coll Cardiol; 2002 Sep; 40(6):1059-66. PubMed ID: 12354428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment.
    Zambon A; Deeb SS; Brown BG; Hokanson JE; Brunzell JD
    Circulation; 2001 Feb; 103(6):792-8. PubMed ID: 11171785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins.
    Zambon A; Bertocco S; Vitturi N; Polentarutti V; Vianello D; Crepaldi G
    Biochem Soc Trans; 2003 Oct; 31(Pt 5):1070-4. PubMed ID: 14505482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common hepatic lipase gene promoter variant predicts the degree of neointima formation after carotid endarterectomy: impact of plaque composition and lipoprotein phenotype.
    Zambon A; Puato M; Faggin E; Bertocco S; Vitturi N; Polentarutti V; Deriu GP; Grego F; Bertipaglia B; Rattazzi M; Vianello D; Deeb SS; Pauletto P
    Atherosclerosis; 2006 Mar; 185(1):121-6. PubMed ID: 16005462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic lipase as a focal point for the development and treatment of coronary artery disease.
    Zambon A; Brown BG; Deeb SS; Brunzell JD
    J Investig Med; 2001 Jan; 49(1):112-8. PubMed ID: 11217140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this gene-nutrient interaction in the Framingham Study.
    Ordovas JM; Corella D; Demissie S; Cupples LA; Couture P; Coltell O; Wilson PW; Schaefer EJ; Tucker KL
    Circulation; 2002 Oct; 106(18):2315-21. PubMed ID: 12403660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hepatic lipase gene promoter polymorphism attenuates the increase in hepatic lipase activity with increasing intra-abdominal fat in women.
    Carr MC; Hokanson JE; Deeb SS; Purnell JQ; Mitchell ES; Brunzell JD
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2701-7. PubMed ID: 10559014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women.
    Carr MC; Ayyobi AF; Murdoch SJ; Deeb SS; Brunzell JD
    Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):667-73. PubMed ID: 11950708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein subclass and particle size differences in Afro-Caribbeans, African Americans, and white Americans: associations with hepatic lipase gene variation.
    Miljkovic-Gacic I; Bunker CH; Ferrell RE; Kammerer CM; Evans RW; Patrick AL; Kuller LH
    Metabolism; 2006 Jan; 55(1):96-102. PubMed ID: 16324926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: The Framingham Offspring Study.
    Couture P; Otvos JD; Cupples LA; Lahoz C; Wilson PW; Schaefer EJ; Ordovas JM
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):815-22. PubMed ID: 10712408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipids, cardiovascular disease, and oral contraceptives: a practical perspective.
    Upton GV
    Fertil Steril; 1990 Jan; 53(1):1-12. PubMed ID: 2403935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic lipase (LIPC) C-514T gene polymorphism is associated with cardiometabolic parameters and cardiovascular risk factors but not with fatty liver in Mexican population.
    Posadas-Sánchez R; Ocampo-Arcos WA; López-Uribe ÁR; Posadas-Romero C; Villarreal-Molina T; León EÁ; Pérez-Hernández N; Rodríguez-Pérez JM; Cardoso-Saldaña G; Medina-Urrutia A; Vargas-Alarcón G
    Exp Mol Pathol; 2015 Feb; 98(1):93-8. PubMed ID: 25550127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.
    Tahvanainen E; Syvanne M; Frick MH; Murtomaki-Repo S; Antikainen M; Kesaniemi YA; Kauma H; Pasternak A; Taskinen MR; Ehnholm C
    J Clin Invest; 1998 Mar; 101(5):956-60. PubMed ID: 9486964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The G-250A polymorphism in the hepatic lipase gene promoter is associated with changes in hepatic lipase activity and LDL cholesterol: The KANWU Study.
    Lindi V; Schwab U; Louheranta A; Vessby B; Hermansen K; Tapsell L; Riccardi G; Rivellese AA; Laakso M; Uusitupa MI;
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):88-95. PubMed ID: 17327141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The -250G>A promoter variant in hepatic lipase associates with elevated fasting serum high-density lipoprotein cholesterol modulated by interaction with physical activity in a study of 16,156 Danish subjects.
    Grarup N; Andreasen CH; Andersen MK; Albrechtsen A; Sandbaek A; Lauritzen T; Borch-Johnsen K; Jørgensen T; Schmitz O; Hansen T; Pedersen O
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2294-9. PubMed ID: 18364377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women.
    Somekawa Y; Umeki H; Kobayashi K; Tomura S; Aso T; Hamaguchi H
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4766-70. PubMed ID: 12364471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic lipase: new insights from genetic and metabolic studies.
    Cohen JC; Vega GL; Grundy SM
    Curr Opin Lipidol; 1999 Jun; 10(3):259-67. PubMed ID: 10431662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.